BGP Litigation has launched a Life Sciences & Technology practice, to be led by Partner Alexander Panov, who is joining the firm from the Pepeliaev Group.
According to BGP Litigation, the firm's Life Sciences & Technology practice will provide "full legal support on issues related to the regulation and circulation of medicines and medical devices, legal issues of healthcare and life sciences law, localization of production, legal aspects of FMCG companies, transactional work with technological assets, legal issues of data protection and circulation, anti-corruption compliance, and GR-interaction with regulatory authorities."
Panov has been practicing Life Sciences law for over ten years, and was Head of Life Sciences at the Pepeliaev Group. According to the BGP Litigation, his expertise covers manufacturing and registration of medicines, construction and equipment of healthcare facilities, and acquisitions of pharmaceutical assets. According to the firm, “Alexander’s experience includes working in legal consulting, in major Russian and international companies, as well as liaising with state authorities.” He is a graduate of HSE University.
“I am happy to become a part of BGP Litigation’s successful and ambitious team,” said Panov. “I hope that the synergy of the expertise of my team and other practices of the firm will allow us to offer the market a new dimension in industrial legal competence, both in the life sciences law and high technology.”
“Alexander Panov’s team has proven to be one of the most talented and efficient teams in the market,” commented BGP Litigation Partner Alexander Vaneev. “That legal services in pharmaceuticals are in high demand is beyond all question. In a relatively short time, Alexander managed to build one of the most successful healthcare practices. And that is in keeping with the dynamic of our firm. In my view, that has made it only logical for his team to join our firm.”
